These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 32250198)

  • 21. Rates of hospitalizations and emergency department visits in patients with asthma and chronic obstructive pulmonary disease taking beta-blockers.
    Brooks TW; Creekmore FM; Young DC; Asche CV; Oberg B; Samuelson WM
    Pharmacotherapy; 2007 May; 27(5):684-90. PubMed ID: 17461703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metoprolol, a beta-1 selective blocker, can be used safely in coronary artery disease patients with chronic obstructive pulmonary disease.
    Camsari A; Arikan S; Avan C; Kaya D; Pekdemir H; Ciçek D; Kiykim A; Sezer K; Akkuş N; Alkan M; Aydoğdu S
    Heart Vessels; 2003 Sep; 18(4):188-92. PubMed ID: 14520486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beta-blockers in COPD: time for reappraisal.
    Lipworth B; Wedzicha J; Devereux G; Vestbo J; Dransfield MT
    Eur Respir J; 2016 Sep; 48(3):880-8. PubMed ID: 27390282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. β-Blockers and the Rate of Chronic Obstructive Pulmonary Disease Exacerbations.
    Mersfelder TL; Shiltz DL
    Ann Pharmacother; 2019 Dec; 53(12):1249-1258. PubMed ID: 31271049
    [No Abstract]   [Full Text] [Related]  

  • 25. Association of beta-blocker use and selectivity with outcomes in patients with heart failure and chronic obstructive pulmonary disease (from OPTIMIZE-HF).
    Mentz RJ; Wojdyla D; Fiuzat M; Chiswell K; Fonarow GC; O'Connor CM
    Am J Cardiol; 2013 Feb; 111(4):582-7. PubMed ID: 23200803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta-blockers in chronic obstructive pulmonary disease: the good, the bad and the ugly.
    Leitao Filho FS; Choi L; Sin DD
    Curr Opin Pulm Med; 2021 Mar; 27(2):125-131. PubMed ID: 33332878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between heart failure, concurrent chronic obstructive pulmonary disease and beta-blocker use: a Danish nationwide cohort study.
    Sessa M; Mascolo A; Mortensen RN; Andersen MP; Rosano GMC; Capuano A; Rossi F; Gislason G; Enghusen-Poulsen H; Torp-Pedersen C
    Eur J Heart Fail; 2018 Mar; 20(3):548-556. PubMed ID: 29159953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. β-blockers for COPD inpatients.
    Suissa S; Ernst P
    Thorax; 2012 Nov; 67(11):936-7. PubMed ID: 23100217
    [No Abstract]   [Full Text] [Related]  

  • 29. Beta-blockers are under-prescribed in patients with chronic obstructive pulmonary disease and co-morbid cardiac disease.
    Neef PA; McDonald CF; Burrell LM; Irving LB; Johnson DF; Steinfort DP
    Intern Med J; 2016 Nov; 46(11):1336-1340. PubMed ID: 27813357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute heart failure with accompanying chronic obstructive pulmonary disease: should we focus on beta blockers?
    Ege MR; Guray U; Guray Y; Yilmaz MB; Yucel O; Zorlu A; Tandogan I
    Herz; 2012 Nov; 37(7):796-800. PubMed ID: 22699995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of beta-blockers in patients with COPD: current perspective.
    Malerba M; Montuschi P; Radaeli A; Pirisi M
    Drug Discov Today; 2015 Jan; 20(1):129-35. PubMed ID: 25238736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beta-blocker, aspirin, and statin usage after first-time myocardial infarction in patients with chronic obstructive pulmonary disease: a nationwide analysis from 1995 to 2015 in Denmark.
    Rasmussen DB; Bodtger U; Lamberts M; Nicolaisen SK; Sessa M; Capuano A; Torp-Pedersen C; Gislason G; Lange P; Jensen MT
    Eur Heart J Qual Care Clin Outcomes; 2020 Jan; 6(1):23-31. PubMed ID: 30608575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Metoprolol CR/XL: advanced formulation of a classical beta-blocker].
    Kobalava ZhD; Gudkov KM
    Kardiologiia; 2003; 43(9):91-100. PubMed ID: 14593374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD.
    Dransfield MT; Rowe SM; Johnson JE; Bailey WC; Gerald LB
    Thorax; 2008 Apr; 63(4):301-5. PubMed ID: 17951276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic update: non-selective beta- and alpha-adrenergic blockade in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure.
    Sirak TE; Jelic S; Le Jemtel TH
    J Am Coll Cardiol; 2004 Aug; 44(3):497-502. PubMed ID: 15358010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Challenges in the Management of Patients with Chronic Obstructive Pulmonary Disease and Heart Failure With Reduced Ejection Fraction.
    Jaiswal A; Chichra A; Nguyen VQ; Gadiraju TV; Le Jemtel TH
    Curr Heart Fail Rep; 2016 Feb; 13(1):30-6. PubMed ID: 26780914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Use of beta blockers in cardiovascular diseases and bronchial asthma/COPD].
    Glaab T; Weiss T
    Internist (Berl); 2004 Feb; 45(2):221-7. PubMed ID: 14991165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardioselective beta-blockers for chronic obstructive pulmonary disease.
    Salpeter SS; Ormiston T; Salpeter E; Poole P; Cates C
    Cochrane Database Syst Rev; 2002; (2):CD003566. PubMed ID: 12076486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. β-blockers and their mortality benefits: underprescribed in heart failure and chronic obstructive pulmonary disease.
    Rutten FH
    Future Cardiol; 2011 Jan; 7(1):43-53. PubMed ID: 21174509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequency of β-Blocker Use Following Exacerbations of COPD in Patients with Compelling Indication for Use.
    Pinner N; Oliver W; Veasey T; Starr J; Eudaley S; Hutchison A; Wargo K
    South Med J; 2019 Nov; 112(11):586-590. PubMed ID: 31682740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.